5-Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional …

BWH Lee, AS Sidhu, IC Francis, MT Coroneo - The Ocular Surface, 2022 - Elsevier
Pterygium is an ultraviolet-related disease characterized by an aberrant, wing-shaped and
active wound-healing process. There is nothing quite as disheartening for the surgeon or …

Evaluating the efficacy and safety of different pterygium surgeries: A review of the literature

M Palewski, A Budnik, J Konopińska - International journal of …, 2022 - mdpi.com
The search for the “gold standard” in the surgical treatment of pterygium has been ongoing
for over two decades. Despite the development of various surgical techniques, recurrence …

Historical considerations and innovations in the perioperative use of mitomycin C for glaucoma filtration surgery and bleb revisions

DS Grover, HL Kornmann, RL Fellman - Journal of Glaucoma, 2020 - journals.lww.com
Although there is a currently a revolution in angle-based procedures, subconjunctival
filtration surgery with mitomycin C (MMC) wound modification remains a vital skill for …

A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients

P Singh, L Sarkar, HS Sethi… - Indian journal of …, 2015 - journals.lww.com
Background: Pterygium is an ocular surface disorder with prevalence rates ranges from
0.3% to 29% in different parts of the world. Vascular endothelial growth factor (VEGF) has …

Surgical techniques and adjuvants for the management of pterygium

ED Patel, MK Rhee - Eye & contact lens, 2022 - journals.lww.com
Objective: To provide an updated review of surgical techniques and adjuvants for the
management of pterygium. Methods: A literature search was conducted in PubMed for …

[HTML][HTML] Bromfenac inhibits TGF-β1–induced fibrotic effects in human pterygium and conjunctival fibroblasts

K Chen, K Lai, X Zhang, Z Qin, Q Fu… - … & Visual Science, 2019 - tvst.arvojournals.org
Purpose: Nonsteroidal anti-inflammatory drugs (NSAIDs) have shown antifibrotic effects on
several diseases. The aims of the present in vitro study were to investigate the antifibrotic …

[HTML][HTML] Comparison between the triamcinolone and bevacizumab subconjunctivals and changes in Interleukin-1 mRNA expression in pterygium

P Syawal, B Budu, M Hatta, MN Massi… - Journal of Taibah …, 2022 - Elsevier
Objectives Pterygium is a fibrovascular external ocular mass that grows from the conjunctiva
into the cornea. The effect of subconjunctival injection of triamcinolone and bevacizumab …

Subconjunctival dexamethasone-assisted conjunctival autograft harvesting versus normal saline during pterygium surgery–A randomized clinical trial

A Meena, A Agrawal, G Parmar… - Indian Journal of …, 2024 - journals.lww.com
Purpose: To evaluate the effect of subconjunctival dexamethasone compared to normal
saline on conjunctival autograft harvesting in patients undergoing pterygium surgery …

[PDF][PDF] Pterygium: A complex and multifactorial ocular surface disease. A review on its pathogenic aspects

HM Serra, MF Suarez, JP Maccio… - Rare Diseases; Avid …, 2018 - academia.edu
Pterygium is an abnormal overgrowth of epithelial and fibrovascular tissue of the bulbar
conjunctiva onto the corneoscleral limbus that may progress invading the superficial corneal …

[PDF][PDF] Comparasion of intraoperative triamcinolone and Bevacizumab with conjuctival autograft alone in pterygium surgery

S Kumar - Indian Journal of Clinical and Experimental …, 2020 - academia.edu
Pterygium is a degenerative condition of subconjuctival tissue that undergoes elstotic
degeneration and proliferates as vascular granulation tissue under the epithelium. This …